Sigma-Aldrich Corp. has acquired Pharmorphix Ltd., a privately held firm based in Cambridge, U.K., that offers solid-form research services to pharmaceutical and biotech markets. Terms of the acquisition, paid in cash, weren't disclosed.
Sigma-Aldrich Corp. has acquired Pharmorphix Ltd., a privately held firm based in Cambridge, U.K., that offers solid-form research services to pharmaceutical and biotech markets.Terms of the acquisition, paid in cash, weren't disclosed.
The St. Louis-based supplier of biochemicals, organic chemicals, chromatography products and diagnostic reagents said the addition of Pharmorphix will broaden its manufacturing services customer base and enhance technology offerings for existing customers.
Sigma-Aldrich said Pharmorphix, which had sales of about $5 million in the past 12 months, won't have a material impact on its sales. Pharmorphix is expected to be neutral to mildly accretive to earnings in 2006, with no initial charges.
Phamorphix employees and existing management team will remain with the company.
Transferring Methods to Compact and Portable HPLC
February 14th 2024The current trend in laboratory equipment design is the miniaturization of laboratory instruments. Smaller-scale HPLC instruments offer benefits that cannot be matched by analytical-scale equipment, especially in the areas of portability, reduced fluid volumes, and reduced operating costs. Yet, the miniaturization of laboratory equipment has brought with it a unique set of challenges, including transferring methods to compact LC. Capillary LC expands the use of LC to applications not currently done using conventional LC in a wide array of application areas, including pharmaceutical, food and beverage, petrochemical, environmental, and oil and gas. Greg Ward, Axcend’s CEO wrote, “Customers want an HPLC system with a small footprint, low flow rates and green chemistry.” Join his podcast where he shares method transfer in these application areas.